Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$0.74 - $1.83 $7,770 - $19,215
-10,500 Reduced 22.82%
35,512 $31,000
Q3 2022

Nov 09, 2022

SELL
$1.51 - $2.88 $3,013 - $5,748
-1,996 Reduced 4.16%
46,012 $72,000
Q2 2022

Aug 10, 2022

BUY
$1.24 - $2.33 $14,880 - $27,960
12,000 Added 33.33%
48,008 $96,000
Q1 2022

May 12, 2022

BUY
$2.0 - $4.9 $12,980 - $31,801
6,490 Added 21.99%
36,008 $84,000
Q4 2021

Feb 10, 2022

SELL
$4.65 - $7.23 $18,716 - $29,100
-4,025 Reduced 12.0%
29,518 $136,000
Q3 2021

Nov 12, 2021

BUY
$7.41 - $10.99 $55,508 - $82,326
7,491 Added 28.75%
33,543 $255,000
Q2 2021

Aug 06, 2021

SELL
$6.35 - $10.0 $58,578 - $92,250
-9,225 Reduced 26.15%
26,052 $252,000
Q1 2021

May 10, 2021

BUY
$7.03 - $16.51 $52,366 - $122,982
7,449 Added 26.77%
35,277 $291,000
Q4 2020

Feb 10, 2021

BUY
$5.76 - $11.95 $103,536 - $214,801
17,975 Added 182.43%
27,828 $191,000
Q3 2020

Nov 13, 2020

SELL
$6.17 - $18.82 $55,480 - $169,229
-8,992 Reduced 47.72%
9,853 $110,000
Q2 2020

Aug 10, 2020

SELL
$1.73 - $6.76 $7,148 - $27,932
-4,132 Reduced 17.98%
18,845 $120,000
Q1 2020

May 21, 2020

BUY
$1.57 - $4.76 $21,980 - $66,640
14,000 Added 155.95%
22,977 $43,000
Q4 2019

Feb 14, 2020

BUY
$1.45 - $4.17 $13,016 - $37,434
8,977 New
8,977 $31,000
Q2 2018

Aug 14, 2018

SELL
$4.75 - $8.0 $92,140 - $155,184
-19,398 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$4.5 - $9.95 $87,291 - $193,010
19,398 New
19,398 $100,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.